The Pharma Data

JANUARY 3, 2021

The Company focuses on reducing attrition in clinical trials and on enhancing drug molecules’ formulation performance through its nanoforming services. This press release contains forward-looking statements, including, without limitation, statements regarding Nanoform’s strategy, business plans and focus.

Containment 52

Containment Bioavailability Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 20, 2021

The formulation is designed to deliver the drug to the Peyer’s patch region of the lower small intestine, where the disease originates, as per the predominant pathogenesis models. Nefecon is a patented oral formulation of a potent and well-known active substance – budesonide – for targeted release.

Trials 52

Trials Containment Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 3, 2020

Food and Drug Administration and European Medicines Agency as we work to bring maribavir to patients.”. Maribavir, an orally bioavailable anti-CMV compound, is the only antiviral agent presently in Phase 3 development for the treatment of post-transplant patients with CMV in SOT or HSCT. About Maribavir. Forward-Looking Statements.

Drugs 52

Drugs Medicine Trials Containment 52

Drug Discovery World

OCTOBER 25, 2023

Here, she discusses with DDW’s Megan Thomas the impact of AI and ML on the drug discovery process. MT: How does AI and ML accelerate the drug discovery process? JV: A key bottleneck in the research and development of a drug is the lengthy experimentation that is required to gain the confidence to run clinical trials.

Drugs 111

Drugs Pharma Companies Clinical Trials Clinical Trials 111

The Pharma Data

DECEMBER 8, 2020

The Company’s pipeline consists of two wholly owned small molecule drug candidates that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Forward-Looking Statements.

Bioavailability 52

Bioavailability Containment Sales Medicine 52

The Pharma Data

NOVEMBER 19, 2020

20, 2020 /PRNewswire/ — Sosei Group Corporation (“the Company”) (TSE: 4565) announces a progress update for its R&D program focused on the design and development of novel drugs targeting the SARS-CoV-2 coronavirus and to treat COVID-19. . TOKYO and CAMBRIDGE, England , Nov. The program was initiated in April 2020.

Development 40

Development Bioavailability Production Drugs 40

Pharmaceutical Technology

NOVEMBER 24, 2022

Understanding how a drug will act in the body, including how it is absorbed, distributed, and eventually eliminated, is a crucial component of drug research. ADME studies require the use of a radiolabeled version of the investigational drug. ADME studies require the use of a radiolabeled version of the investigational drug.

Bioavailability 130

Bioavailability Manufacturing Drugs Production 130

Camargo

AUGUST 22, 2021

The first two were published in December of 2014: Providing Regulatory Submissions in Electronic Format — Submissions Under Section 745A(a) of the Federal Food, Drug, and Cosmetic Act mandates that NDAs, ANDAs, and INDs be submitted in electronic format. 3.1.1: Bioavailability Study Reports. 3.1.1: Bioavailability Study Reports.

Containment 190

Containment Bioavailability Cosmetics Packaging 190

Drug Discovery World

DECEMBER 7, 2022

Different polymorphs of the same active pharmaceutical ingredient (API) can have profound effects on solubility, permeability, and bioavailability, as well as manufacturability. As a result, the drug was removed from the market until the manufacturing issues were remedied. The financial losses to the company were significant. .

Bioavailability 52

Bioavailability Manufacturing Production Development 52

Pharmaceutical Technology

AUGUST 3, 2022

The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development. Yet commercialising a drug is no easy journey, hence why just 10% of new drug candidates succeed in making it to market. One size (never) fits all.

Development 130

Development Production Manufacturing Bioavailability 130

The Pharma Data

JANUARY 27, 2021

Construction of commercial drug manufacturing facility in Germany. Psychedelic transdermal and sublingual drug formulation development. Vektor will position itself for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

Drug Discovery World

AUGUST 12, 2022

These can have better properties than their parents, including preferable stability, solubility, bioavailability, and manufacturability. The post Addressing the challenge of salt forms in drug discovery appeared first on Drug Discovery World (DDW). Some 5% of commercially available research compounds aresold as salt forms.

Drugs 52

Drugs Bioassay Development Research 52

FDA Law Blog

JANUARY 23, 2023

Livornese — Last month, Congress took a big step towards improving clinical trial diversity by requiring sponsors of most drug and device clinical studies to submit a diversity action plan when they submit key trial documents to the Food and Drug Administration (FDA).

Trials 59

Trials Clinical Trials Clinical Trials Drugs 59

Pharmaceutical Technology

MAY 10, 2023

Within the pharmaceutical industry, it is critical to measure particle size as it influences surface area and porosity, impacting a drug’s bioavailability, effectiveness, and shelf life. Alternatively, they can come as a product component of formulations such as cleaning agents and polymers.

Contamination 130

Contamination Filler Bioavailability Production 130

The Pharma Data

MAY 14, 2021

The natural green tea contained by this formula, and the broccoli leaf extracts are also powerful ingredients. Statements on this website have not been evaluated by the Food and Drug Administration. It’s less than what you’d pay for fancy exotic groceries that you don’t even like eating.

Packaging 52

Packaging Packaging Production Bioavailability 52

The Pharma Data

NOVEMBER 17, 2020

LYT-100 is a deuterated, oral small molecule designed to overcome the challenges associated with pirfenidone, an approved and marketed anti-inflammatory and anti-fibrotic drug. The therapeutic dose of pirfenidone approved by the US Food and Drug Administration (FDA) for the treatment of IPF is 801 mg three times a day. About LYT-100.

Production 52

Production Trials Bioavailability Drugs 52

The Pharma Data

MAY 16, 2021

Contains a unique “living chemistry” that was poorly understood until recently…. I also started to have some dizziness and nausea from the drugs so I looked for another solution…. I also started to have some dizziness and nausea from the drugs so I looked for another solution….

Production 52

Production Containment Research Doctors 52

Pharmaceutical Technology

APRIL 12, 2023

Evidence suggests that API manufacturing is gaining in complexity, as well as sophistication, and therefore adding to the risk profile of drug development. The ingredients used in these drugs are high potency, even at small doses, and pose a risk to both human health and cross-contamination with other drugs in a manufacturing environment.

Manufacturing 130

Manufacturing Production Containment Contamination 130

Pharmaceutical Technology

MARCH 7, 2023

But cost-effectiveness in drug-loading and production speed relies on dosing accuracy. Safety issues must also be addressed, such as containment and potential ignition factors. Frewitt’s expertise also includes solutions to the API containment space, with both rigid and flexible isolators.

Production 130

Production Containment Bioavailability Manufacturing 130

Pharmaceutical Technology

JUNE 14, 2023

The number of high-potency drug approvals has increased over the last decade, driven by the increasing use of APIs (Active Pharmaceutical Ingredients) in the pipeline and among marketed drugs. Premium specialized equipment is necessary because high containment facilities call for the separation of the operator from the product.

Containment 130

Containment Manufacturing Contract Manufacturing Bioavailability 130

Pharmaceutical Technology

FEBRUARY 3, 2023

In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.

Contamination 130

Contamination Manufacturing Containment Production 130